Liquid Partners With Polycade to Release Retro Gaming Titles
VANCOUVER, British Columbia, Sept. 30, 2020 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: […]
Harrow Health Appoints Larry Van Horn to its Board of Directors
NASHVILLE, Tenn., Sept. 30, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today announced the appointment of Larry Van […]
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
Project: AI based Assay Development for carbapenem-resistance based on porin loss and efflux pump overexpression in Gram-negative bacteriaProject is part […]
uniQure to Participate in Multiple Upcoming Industry Conferences in October
LEXINGTON, Mass. and AMSTERDAM, Sept. 30, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]
BioCryst’s Oral Factor D Inhibitor, BCX9930, Shows Clinical Benefit as Monotherapy Through 400 mg bid in Treatment-naïve PNH Patients
RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced new data from treatment-naïve […]
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
–Preparing to Submit NDA in Q4–DUBLIN, Ireland and CHICAGO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) […]
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkin’s Lymphoma
MOUNTAIN VIEW, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on […]
Altimmune to Present at Upcoming Investor Conferences
GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management […]
Q&K Announces First Half of Fiscal Year 2020 Unaudited Financial Results
SHANGHAI, China, Sept. 30, 2020 (GLOBE NEWSWIRE) — Q&K International Group Limited (NASDAQ: QK) (“Q&K” or the “Company”), a leading […]
Placements with International markets by Willis Towers Watson P&C Hub have increased by 67 percent year on year to reach $525m in premium
LONDON, Sept. 30, 2020 (GLOBE NEWSWIRE) — In a market update for clients, Willis Towers Watson (NASDAQ: WLTW), a leading […]
